BioWorld

May 21, 2012

View Archived Issues

BioWorld Stock Report For Public Biotechnology Companies

Stock Gainers and Losers For The Week

Money Raised by Biotech Jan. 1 - May 18, 2012

Money Raised by Biotech 2012 Vs. 2011

Biotech-Biotech Collaborations: Modified And Terminated Agreements: April 1 - May 18, 2012

Manufacturing, Marketing And Distribution Agreements Between Biotech Companies: April 1 - May 18, 2012

Biotechnology Company Deals With Other Biotechnology Companies: April 1 - May 18, 2012

Top Deals Between Biotech Companies: 2012

Investment Practice Changes By LPs Could Help Startups

The Ewing Marion Kauffman Foundation issued a report this month blaming the lackluster returns from venture capital on a lack of oversight from limited partners (LPs) that invest in the funds. Read More

Novartis Expands R&D as Other Pharmas Cut Back

At a time when many big pharmas are trimming internal research programs, Novartis AG has been quietly expanding. Read More

Week in Review

Word on the Street

Week in Washington

Today's news in brief

BioWorld

BioWorld briefs for Jan 16, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Jan. 16, 2026.

SERPINB1 as potential biomarker for spinocerebellar ataxia type 2

BioWorld Science

Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...

Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal

BioWorld

With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...

Illustration of human body surrounded by DNA, cell and drug icons

Cell/gene therapy sector now sustainable; China competition mounting

BioWorld

There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...